Barry Lynch

Barry Lynch is Sr. Director Business Development at Alamar Biosciences, Inc.
With over 25 years’ experience in business development across the life sciences industry his focus has been on supporting the introduction of new breakthrough proteomic and spatial transcriptomic technologies. He has held leadership positions at 10X Genomics, Ultivue, Advanced Cell Diagnostics and Invitrogen. His current focus is on supporting the CNS Applications of the NULISA technology.